Product Details

Braftovi 50 mg Capsules**

Encorafenib
50 mg
Capsule

ROA

Oral

Applicant Name

Pfizer Specialties Ltd

NRN

A4-100330

Status

Active


Composition

Each hard capsule contains: Encorafenib 50 mg. Excipients: Capsule content - Copovidone (E1208) Poloxamer 188 Cellulose microcrystalline (E460i) Succinic acid (E363) Crospovidone (E1202) Silica colloidal anhydrous (E551) Magnesium stearate (E470b) Capsule shell - Gelatin (E441) Titanium dioxide (E171) Iron oxide red (E172) Iron oxide yellow (E172) Iron oxide black (E172)  

ATC Code

L01EC03  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

28's (in polyamide/aluminium/PVC/aluminium/ PET/paper perforated unit dose blisters)  

Product Description

Hard capsule (capsule). Orange opaque cap and flesh opaque body, printed with a stylised “A” on the cap and “LGX 50mg” on the body. The length of the capsule is approximately 22 mm

Manufacturer Name

Catalent Pharma Solutions LLC

Manufacturer Country

UNITED STATES OF AMERICA  

Approval Date

2023-01-26  

Expiry Date

2028-01-25